GlassScriptPhysician profile
Judith A Sperling
NPI 1710037767
$949.92
in general payments reported to CMS, 2019-2025
10 companies · $50.68 in 2025
The $50.68 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.45 · 2021: $15.46 · 2022: $38.43 · 2023: $101 · 2024: $724 · 2025: $50.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $500 · Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $500.00 |
| Food and Beverage | $375.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $500.00 | 2024 | Promogran |
| Treace Medical Concepts, INC. | $129.45 | 2023-2024 | |
| Spr Therapeutics, INC | $129.28 | 2024 | Sprint Pns System |
| Organogenesis INC. | $38.43 | 2022 | |
| Smith+Nephew, INC. | $37.40 | 2024 | Stravix Pl, Stravix, Grafix Xc |
| Bioventus LLC | $35.91 | 2019-2021 | |
| Stryker Corporation | $30.20 | 2025 | Clottriever Bold Catheter |
| Medtronic, INC. | $20.48 | 2025 | Inceptiv |
| Boston Scientific Corporation | $15.37 | 2024 | |
| Nevro Corp. | $13.40 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Sperling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.